Complete your personal information for a more tailored experience
for the best life sciences journalism in the industry
Brazil — His nicotine-yellow eyes and haunted stare gave José de Moraes the look of a man who had been to the brink of death and back again
A 54-year-old city council employee, de Moraes caught yellow fever two months ago
the same strain that has killed nearly 200 people in Brazil since January and infected at least three times more
Today he is still too weak to climb the steps to his first-floor apartment on the edge of this quiet country town
And he is still spooked by the force of the disease
describing how the virus attacked his kidneys
The pain started in his back and took over his whole frame
and delirium that he no longer recognized anyone
The virus that de Moraes caught is part of a broader outbreak that has taken authorities here by surprise
Although Brazil experiences what is known as a “sylvatic” cycle of yellow fever — in which the virus is spread between mosquitoes and monkeys in the jungle — the current outbreak has fanned far beyond the Amazon jungle and out to the coast
and raised fears of an epidemic in Brazil’s urban areas that could be devastating if not quickly contained
It is the worst outbreak of yellow fever in this country in recent memory
Although Brazil appears to be moving quickly to administer vaccines and take other steps to stop the spread of the virus
it is still struggling to get the outbreak under control
And while the outbreak is still in the “syvlatic” cycle
a rash of monkey deaths in big cities has raised fears the situation could still get much worse before it gets better
the World Health Organization added parts of São Paulo
and Rio de Janeiro states to a list of areas at risk
“Yellow fever virus transmission continues to expand towards the Atlantic coast of Brazil,” the WHO said in a statement
The vaccine against yellow fever is highly effective, but at times has been in short supply
the WHO dispatched 3.5 million additional doses of its vaccine to Brazil from an international emergency stockpile
Brazil’s Ministry of Health has also adopted the WHO recommendation that one dose of the vaccine is sufficient, not two as previously advised, and said it is preparing contingency plans to recommend one-fifth of the normal dose, a strategy that proved effective recently in the Democratic Republic of Congo
The last urban epidemic of yellow fever in Brazil
But the disease is still spread by Haemagogus and Sabethes forest mosquitoes
A roundup of STAT's top stories of the day
An hour’s drive down dirt roads from Ipanema is the tiny hamlet of Santa Constância
where Leonel Ferreira Neto grew coffee and sugar cane
possibly while clearing forest on the steep hills beside his neat farmhouse
remembered he had seen a dead monkey — a sign the family now know means yellow fever could be present
her father trusted vaccines as little as he trusted school
which he only let his six children attend for a year each
“He did not believe in these things,” she said
after running up a vertiginous slope in flip-flops to herd a couple of cows
His widow said he spent weeks in the hospital before dying
taking on the jaundiced color for which the disease is known
The family had never seen yellow fever in the town
rural state have seen outbreaks before — 16 people in Minas Gerais died of yellow fever in 2001
Adults were advised to get vaccinations every 10 years by the state and federal government
Yet just 30 percent of the population of Ipanema was vaccinated
The widespread deaths of monkeys can be a signal that the disease is spreading
a professor of zoology and primate specialist at the Federal University of Espírito Santo
who has documented the deaths of over 1,200 since January
monkeys were found to have died from yellow fever in towns in Minas and São Paulo states
But “authorities were slow to perceive the problem,” Lucena said
city health director Weverton Rodrigues said adults don’t bother keeping their vaccinations up to date
“Unfortunately I see the culture of our country as very short-sighted
“A problem comes up and let’s deal with it.”
Some specialists said Minas Gerais should have worked harder to vaccinate its population
“The human cases in Minas Gerais are the result of a failure in vaccination cover,” said Jessé Alves
an infectious diseases specialist at the Emilio Ribas hospital in São Paulo
a spokeswoman for the Minas Gerais health secretariat said the population’s demand for the vaccine had always been low
and that 77 percent of the state was now vaccinated.)
Yellow fever vaccinations were not recommended in Espírito Santo state
which borders Minas Gerais on Brazil’s eastern coast
Since January it has confirmed 148 cases and 44 deaths from the disease
where residents can schedule vaccinations online
the coverage is even higher: 92 percent of its 333,000 people
according to the municipal health secretary
the director of health vigilance in Espírito Santo
She had been told by specialists that Vitória’s metropolitan area was basically free of yellow fever
Then laboratory results confirmed yellow fever in 22 monkeys that died there
Other towns near Vitória have been slow to vaccinate residents
only 49 percent of the population were vaccinated
In February its police force went on strike
leading to a crime wave and hundreds of deaths
Rodrigues said Brazil’s Ministry of Health did not always supply the quantity of vaccines they needed
She was forced to prioritize rural areas where cases had been found over those that had yet to report them
a rural municipality surrounded by impacted areas that did not immediately report cases
She had to argue to get the ministry to send her enough doses of vaccine for Muniz Freire too
Six deaths have since been confirmed there
“It makes you want to cry,” Rodrigues said
“You are facing a situation that you know what the solution is
but the decision to put the vaccine there is not in your power.” Recently another 200,000 doses of the vaccine were held up for a week
In March cases appeared in Casimiro de Abreu
Now the state is working to vaccinate its entire 16 million-plus population
concerned yellow fever could spread to Aedes aegypti mosquitos in cities like Rio
where almost a quarter of its 6.5 million people live in the densely packed
When one clinic outside the Complexo do Alemão favela opened on a recent morning
many forming a line for yellow fever vaccines
“I tried last week and there was none here,” said Viviane Duarte
some waited three hours in a line that stretched a block
Staff at both centers said they were vaccinating around 500 people a day
said she was getting vaccinated because “where I live
infectious disease
public health
Vaccines
To submit a correction request, please visit our Contact Us page
Reporting from the frontiers of health and medicine
Metrics details
The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate hepatitis C virus (HCV) infection by 2030
efforts have been undertaken to achieve this goal; there are
It is important to understand the disease profile in different regions of the country in order to design strategies to fight the disease nationwide
The objective of this study was to analyse the time trend of the incidence and mortality of hepatitis C in Brazil during the period from 2008 to 2018 according to sociodemographic and clinical characteristics
All newly diagnosed cases of hepatitis C reported between 2008 and 2018
The indicators were obtained from the databases of the Brazilian Ministry of Health
136,759 newly diagnosed cases of hepatitis C were reported considering anti-HCV and HCV RNA positivity
and 271,624 newly diagnosed cases were reported considering one or another positive test
The majority of the records were concentrated in the Southeast (61%) and South (26.2%) Regions
The joinpoint regression model indicated an increasing trend in the detection rate of hepatitis C in Brazil
but there was a decreasing trend in the mortality rate during the period analysed
Differences were observed in the time trend of hepatitis C and in the sociodemographic and clinical characteristics in different regions of Brazil
These data can provide support to design strategies for the elimination of hepatitis C in Brazil
and regional inequalities lead to differences in diagnosis and access to treatments
of fundamental importance to conduct epidemiological studies that contribute to characterization of the disease in different regions of the country
in order to contribute to the design of strategies for combating and eliminating hepatitis C throughout Brazil
There are no recent studies in Brazil on the trend behavior of the disease in its different regions
the objective of this study is to analyse the time trend of the incidence and mortality of hepatitis C in Brazil during the period from 2008 to 2018
according to sociodemographic and clinical characteristics
the Brazilian Ministry of Health database provides data on both confirmation criteria for the entire study period
in the present study we present data for both criteria from 2008 to 2018
Hepatitis C by spatial units (two indicators):
Number and detection rate per 100,000 inhabitants of individuals who were anti-HCV positive and HCV RNA positive;
Number and detection rate per 100,000 inhabitants of individuals who were anti-HCV positive or HCV RNA positive;
Hepatitis C by sociodemographic and clinical characteristics (seven indicators):
Number and detection rate of hepatitis C per 100,000 inhabitants by sex (male and female) and sex ratio;
Number and proportion of confirmed cases of hepatitis C by race/colour (White; Black; Asian; Mixed
Number and detection rate per 100,000 inhabitants by age group and year of notification (< 5 years; 5–9 years; 10–14 years; 15–19 years; 20–24 years; 25–29 years; 30–34 years; 35–39 years; 40–44 years; 45–49 years; 50–54 years; 55–59 years; 60 years or more);
Number and percentage of hepatitis C by level of education and year of notification (Illiterate; first to fourth grade incomplete; completed fourth grade; fifth to eighth grade incomplete; completed elementary school; secondary school incomplete; completed secondary school; tertiary school incomplete; completed tertiary school; unknown; not applicable);
Number and proportion of confirmed cases of hepatitis C by likely source/mechanism of infection (Sexual; transfusion; drug use; vertical transmission; work accident; haemodialysis; household; others; unknown/left blank);
Number and proportion of confirmed cases of hepatitis C by association with HIV/AIDS (yes; no; unknown);
Number and proportion of confirmed cases of hepatitis C coinfected with HIV by macro-region (North; Northeast; Southeast; South; Central-West);
Number of deaths due to hepatitis C and mortality rate (per 100,000 inhabitants) as underlying cause
Number of deaths due to hepatitis C and mortality rate (per 100,000 inhabitants) as the underlying cause
by place of residence and year of occurrence
descriptive analysis of the variables was conducted
indicators were described as absolute and relative frequencies and measures of central tendency (mean and standard deviation)
Scatter plots with smoothed regression lines were generated to evaluate the relationship between the Brazilian and regional rates
For comparison of detection rates before and after the change in the notification process for confirmed cases of hepatitis C
descriptive exploratory spatial analysis was conducted
significance level of 5% and confidence interval of 5% (95% CI) were considered
The results of the analysis are displayed in graphs
Netherlands) and QGIS (2.14.11 Open Source Geospatial Foundation
As this study used data from the public domain
evaluation by the Research Ethics Committee was waived
Hepatitis C detection rate considering A anti-HCV and HCV-RNA positivity and B considering anti-HCV or HCV-RNA positivity, by region of residence and year of notification. Brazil, 2008–2018
Distribution of hepatitis C detection rate* in the analysed period
considering A anti-HCV and HCV-RNA positivity and B considering anti-HCV or HCV-RNA positivity
*Each data point represents incidence rate of one year
Relation between regional and national hepatitis C detection rate considering A anti-HCV and HCV-RNA positivity and B considering anti-HCV or HCV-RNA positivity
Spatial distribution of the hepatitis C detection rate in Brazil considering A anti-HCV and HCV-RNA positivity and B considering anti-HCV or HCV-RNA positivity
This study has presented important data regarding the detection and mortality rate of hepatitis C in Brazil in recent years
as well as differences in the epidemiological profile of the disease in different regions of the country
The main explanation for the increased incidence of HCV in these age groups involves changes in the mechanisms of disease transmission over the years
have led to changes in the disease profile in Brazil
This finding is corroborated by the data on level of education
where an increase was observed in the proportion of individuals who were illiterate and those who had not completed secondary or tertiary education
the decreasing trend in HCV-HIV coinfection in the country may reflect increased access to diagnostic tests over the years
as the prevalence of HCV-HIV coinfection could have been overestimated in previous years
due to a greater demand for test orders in individuals who were previously infected with HIV
The worldwide impacts of the COVID-19 pandemic have jeopardized all the advances observed in recent years
not only due to the evident impact on the entire health system
but also due to the lack of investigations that evaluate the relationship between the two viruses
the notification system does not allow for separate analysis according to the diagnostic method (anti-HCV or HCV-RNA)
so we were unable to differentiate between active and past infection in our analyses
the increasing trends observed for some indicators
when the confirmation criteria was changed in Brazil
This study provides important data regarding the behaviour of hepatitis C in Brazil over a 10-year period
A change was observed in the epidemiological profile of the disease
caused mainly by changes in diagnostic confirmation criteria and the introduction of new medications that have contributed to reduced mortality in recent years
Also evident are the differences in the disease profile in different regions of Brazil
as a result of regional differences related to the sociodemographic profile and health and social infrastructure conditions
with strategies developed according to the population profile of each region of Brazil
with expanded diagnosis for all risk groups
in addition to the development of prevention strategies through health education
which will make it possible to slow contagion and promote awareness so that the population will seek testing centres
and the industry is also needed to guarantee access to treatment for all individuals who are infected
Only then will it be possible to eliminate hepatitis C in Brazil
World Health Organization. Global hepatitis report 2017. 2017. https://apps.who.int/iris/bitstream/handle/10665/255016/9789?sequence=1
Prevalence and risk factors of Hepatitis C virus infection in Brazil
2005 through 2009: a cross-sectional study
World Health Organization. Global health sector strategy on viral hepatitis 2016–2021. Towards ending viral hepatitis. 2016. https://apps.who.int/iris/bitstream/handle/10665/246177/WHO?sequence=1
Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: is the global hepatitis C elimination strategy at risk
Instituto Brasileiro de Geografia e Estatística. Portal do IBGE. https://www.ibge.gov.br/
Transição epidemiológica e o estudo de carga de doença no Brasil
Brasil. Atlas de Vulnerabilidade Social. http://ivs.ipea.gov.br/index.php/pt/
Brasil. Ministério da Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. Indicadores e Dados Básicos das Hepatites nos Municípios Brasileiros. http://indicadoreshepatites.aids.gov.br/
Permutation tests for joinpoint regression with applications to cancer rates
Hepatitis C worldwide and in Brazil: silent epidemic–data on disease including incidence
Health conditions and health-policy innovations in Brazil: the way forward
Hepatites B e C em usuários de drogas injetáveis vivendo com HIV em São Paulo
Brasil [Hepatitis B and C among injecting drug users living with HIV in São Paulo
Co-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlates
Hepatitis C disease burden and strategies for elimination by 2030 in Brazil
Exposure source prevalence is associated with gender in hepatitis C virus patients from Rio de Janeiro
Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study)
Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort
Higher incidence of HCV in females compared to males who inject drugs: a systematic review and meta-analysis
Evaluation of a strategy for identification of hepatitis C virus carriers in outpatient and emergency units: contribution to the microelimination of hepatitis C in Brazil
Seroprevalence of hepatitis B and C in Brazilian army conscripts in 2002: a cross-sectional study
Likely transmission of hepatitis C virus through sharing of cutting and perforating instruments in blood donors in the State of Pará
Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review
Global prevalence of hepatitis C virus in children in 2018: a modelling study
Hepatitis C virus infection status and associated factors among a multi-site sample of people who used illicit drugs in the Amazon region
Perfil clínico-epidemiológico da hepatite C na região norte do Brasil entre 2012 e 2015
Hepatitis C: evaluation of outcomes and georeferencing of cases in Santa Cruz do Sul
HCV genotype profile in Brazil of mono-infected and HIV co-infected individuals: A survey representative of an entire country
Changes in liver-related mortality by etiology and sequelae: underlying versus multiple causes of death
Hepatitis C virus infection mortality trends according to three definitions with special concern for the baby boomer birth cohort
Impact of COVID-19 on TB diagnosis in Northeastern Brazil
Impact of the COVID-19 pandemic on the diagnosis of new leprosy cases in Northeastern Brazil
and disorders attributed to alcohol use: global Burden of Disease in Brazil
Download references
Rodrigo José Videres Cordeiro de Brito & Patrícia Muniz Mendes Freire de Moura
Universidade Federal Do Vale Do São Francisco (UNIVASF)
Leonardo Feitosa da Silva & Carlos Dornels Freire de Souza
The authors declare that they have no competing interests
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
unless otherwise stated in a credit line to the data
Download citation
DOI: https://doi.org/10.1186/s12879-022-07063-5
Anyone you share the following link with will be able to read this content:
a shareable link is not currently available for this article
Samarco Mineracão's Alegria iron ore mine is in Brazil's Iron Quadrangle
Samarco Mineracão (50% BHP Billiton
Samarco Mineracão’s Alegria iron ore mine is in Brazil’s Iron Quadrangle
about 4.5km north of the depleted Germano deposit
within the districts of Mariana and Ouro Preto in the state of Minas Gerais
The process plant pumps concentrate via a slurry pipeline to facilities at Ponta Ubu on the Atlantic coast that include two pelletising plants and a shipping quay
BHP Billiton and CVRD (Vale) each has a 50% holding in Samarco
The operation employed 1,336 people directly and more than 2,000 via contractors in 2005
The company implemented an optimisation project to increase concentrator and pelletisation capacity in the short term
It also invested in a new concentrator and pelletisation plant
port improvement and a second slurry pipeline that began operations in 2008
Samarco produced 8.5Mt of iron ore in 2008
the second and third pellet plants were temporarily suspended
While the two pellets have subsequently been restarted
they will continue operations based on the demand globally
The deposit consists of low-grade itabiritic ore
Alegria’s certified mineral reserves totalled 769MT by 30 June 2009 graded at 44.3% Fe
Probable resources stood at 821Mt at 41.5% Fe
Measured resources totalled 1238Mt at 42.2% Fe while indicated resources were 682Mt at 38.1% Fe
loaded by front-end loaders into 177t-capacity trucks and taken to a crushing and screening plant in the blending yard
The ore is blended and stored before transport by belt conveyors to the surge pile
An overland conveyor system transports the ore over a distance of 4km to the beneficiation plant at Germano
At the Germano beneficiation plant the ore is screened
crushed and classified to feed the primary mills
This circuit assures sufficient reduction of the iron ore particles
with the ultrafine material being removed in cluster cyclones before conventional flotation where waste material such as silica is separated from the iron particles
The ore is reground and enters a column flotation circuit.The addition of a roller press in 2004 improved productivity by 7%
The resulting concentrate is slurried with water for pipeline transport
The concentrator is capable of an annual production of 24Mt of iron-ore concentrates a year
Its output in the 2008 financial year was 8.5Mt
The slurry pipeline takes ore from the Germano plant to the Point Ubu pellet plant and shipping facility at Espírito Santo on the Atlantic coast
this iron ore slurry pipeline is the world’s longest and offers environmental safety and 99% average availability
The new slurry pipeline built in 2008 also measures 396km
Two pump stations and two valve stations regulate internal pressures and maintain flows at an average speed of 6km/h with a flow rate of 1,200m³/h
is now operating at over 15Mt/y owing to advances in pumping and monitoring technology
A new pipeline will be built in conjunction with the new concentrator and pellet plant
incoming slurry is thickened and then stored in tanks that feed vacuum filters
These remove the remaining water from the slurry
The concentrate’s moisture content is adjusted and limestone
It is then conveyed to the balling discs for pelletising
The pellets are screened and classified by size before being fired in the induration furnace
Oversize and undersize materials return to the balling discs
Fired pellets are conveyed to the port stockpile area
The final product is direct reduction and blast furnace pellets for steelmaking
The plant has an annual production capacity of 13Mt of pellets
Surplus concentrates are sold as pellet plant and sinter feed
The pelletising facility on the coast enables Samarco to operate its own port facility at Point Ubu
which can accommodate two vessels of up to 170,000t
The 313m-long by 22m-wide shiploading pier also receives carriers and tankers bringing coal and fuel oil for the pelletising plant
The third pellet-plant project was approved in October 2005
The new concentrator has a capacity of 7.5Mt/y
Outotec supplied the pellet indurating furnace for the third plant in 2007 under a $200m contract
The pellet plant increased yield capacity by 7.6Mt/y and altered the blast furnace:direct-reduction pellet output split to 50:50
The installation of the third pellet plant enabled Samarco to process nearly 24Mt/y of ore concentrate
It allowed Samarco to produce approximately 21.6Mt of pellets every year
the fourth pellet plant project with capacity of 8.3Mt/y was approved
A third slurry pipeline running parallel to the two existing pipeline will be installed as part of the project
The new pipeline that will link the mine with the fourth pellet plant and is designed to carry 20Mt/y
An estimated $3bn will be invested in the fourth pellet plant project
The plant is anticipated to go operational by the first half of 2014
The key to Samarco’s expansion has been the Guilman-Amorin hydro-electric plant
Samarco has a 49% interest in this project
in partnership with Companhia Siderúrgica Belgo-Mineira
The power plant has a capacity of 140MW from four 35MW turbines
Give your business an edge with our leading industry insights
View all newsletters from across the GlobalData Media network